Table 3 Comparison of different methods for the determination of antinuclear antibodies (ANA) and ANA-specific autoantibodies.

From: CytoBead ANA 2 assay - a novel method for the detection of antinuclear antibodies

 

CytoBead ANA

Cohen’s κ* (95% CI)

Difference (%)

(95% CI)

p**

 

Neg

Pos

Classical ANA IIF

 

0.74

(0.61–0.88)

9.71

(3.39–16.03)

0.006

Neg

29

11

Pos

1

62

 

CytoBead ANA

 
 

Neg

Pos

BioPlex

 

Anti-SS-B/La

0.9

(0.76–1.00)

1.79

(−0.67–4.24)

0.500

Neg

100

2

Pos

0

10

Anti-CENP/CENP-B

0.9

0.72–1.00

−0.89

(−2.64–0.85)

1.000

Neg

106

0

Pos

1

5

Anti-Sm

0.76

0.56–0.96

−4.46

(−8.29 - −0.64)

0.062

Neg

98

0

Pos

5

9

Anti-RNP/Sm

0.7

0.41–0.98

1.79

(−1.70–5.27)

0.625

Neg

103

3

Pos

1

5

Anti-dsDNA

0.72

0.51–0.93

3.57

(−0.66–7.81)

0.212

Neg

97

5

Pos

1

9

Anti-Scl70

0.79

0.51–1.00

0

(−2.47–2.47)

1.000

Neg

106

1

Pos

1

4

Anti-SS-A/Ro

0.87

0.77–0.96

4.46

(−0.09–9.02)

0.125

Neg

66

6

Pos

1

39

Anti-Jo-1

0.88

0.66–1.00

0.89

(−0.85–2.64)

1.000

Neg

107

1

Pos

0

4

  1. *Inter-rater agreement analysis.
  2. **McNemar’s test.
  3. CENP - centromere; dsDNA - doubles-stranded DNA; RNP - ribonucleoprotein, Scl70 - scleroderma 70 kDA antigen, topoisomerase I; SS-A - Sjogren’s antigen A; SS-B - Sjogren’s antigen B.